# Bioequivalence Study for an Isotretinoin

> **NCT01863615** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 36 (actual)

## Conditions studied

- Skin Infections (Acne)

## Interventions

- **DRUG:** Isotretinoin 40 mg
- **DRUG:** Isotretinoin 40 mg

## Key facts

- **NCT ID:** NCT01863615
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08-26
- **Primary completion:** 2011-09-23
- **Final completion:** 2011-09-23
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01863615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01863615, "Bioequivalence Study for an Isotretinoin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01863615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*